Food And Drug Administration Commissioner raises concern over purchase of CBD services and products

Food And Drug Administration Commissioner raises concern over purchase of CBD services and products

Outgoing U.S. Food and Drug Management (Food And Drug Administration) Commissioner Scott Gottlieb indicated concern concerning the country’s leading drugstore chains attempting to sell CBD services and products.

Walgreens has recently announced which they will begin selling CBD-infused aerosols, ointments, balms, and spots in around 1,500 shops throughout nine states where medical cannabis is already legal. Rival drugstore CVS Pharmacy, meanwhile, has introduced CBD topicals in around 800 shops across eight states.

During a House Appropriations Committee hearing on Wednesday, Gottlieb raised concern about Walgreens and CVS stepping in to the cannabis market. Continue reading